US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

COYA THERAPEUTICS INC

4.28

+0.25006.20%

Post-market: 4.280.00000.00%18:49 EST

Volume:385.31K

Turnover:1.64M

Market Cap:89.56M

PE:-3.86

High:4.37

Open:4.11

Low:4.06

Close:4.03

52wk High:8.29

52wk Low:3.94

Shares:20.92M

Float Shares:16.83M

Volume Ratio:0.75

T/O Rate:2.29%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.1082

EPS(LYR):-0.9765

ROE:-62.18%

ROA:-37.15%

PB:3.28

PE(LYR):-4.38

Loading ...

Overview Company News Filings

Coya Therapeutics, Inc. (COYA) Receives a Buy from Lake Street

COYA-302: De-Risked Treg Platform With Compelling FTD Data and ALS Phase 2 Catalyst Supporting Buy Rating

Coya Therapeutics: Early COYA 302 Validation, Regulatory De-Risking, and Upcoming Catalysts Support Buy Rating

BRIEF-Coya Therapeutics Announces Results Of Investigator-Initiated Study Of Ld Il-2 And Ctla4-Ig

Coya Therapeutics Reports Positive Results from FTD Study of Low-Dose IL-2 and CTLA4-Ig Combination Therapy

Coya Therapeutics Announces Results of Investigator-Initiated Study of Ld Il-2 and Ctla4-Ig Demonstrating Treg Enhancement and Cognitive Stability in Frontotemporal Dementia Patients

THOMSON REUTERS

BRIEF-Coya Therapeutics Announces U.S. FDA Acceptance Of Investigational New Drug Application For COYA 302

FDA Accepts IND Application for Coya Therapeutics’ COYA 302 for Frontotemporal Dementia

Coya Therapeutics Announces U.S. FDA Acceptance of Investigational New Drug (Ind) Application for Coya 302 for the Treatment of Frontotemporal Dementia (Ftd)

THOMSON REUTERS

BRIEF-Coya Therapeutics Receives Clinical Trial Application Acceptance From Health Canada

Coya Therapeutics Secures Health Canada Approval to Begin ALS Trial

Coya Therapeutics Inc - Alstars Trial Underway in US and Canada

THOMSON REUTERS

Coya Therapeutics Receives Clinical Trial Application (Cta) Acceptance From Health Canada to Proceed With the Coya 302 Alstars Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

THOMSON REUTERS

Coya Therapeutics Receives $4.2 Million Milestone Payment for ALS Trial Initiation

Coya Therapeutics Begins Dosing ALS Patients in ALSTARS Trial of COYA 302

Coya Therapeutics Announces Patients Have Been Dosed in the Alstars Trial of Coya 302 for the Treatment of ALS

THOMSON REUTERS

Coya Therapeutics to Join Evercore Healthcare and CTAD Conferences

Coya Therapeutics reports $3.6 million collaboration revenue for Q3 2025

Coya Therapeutics Inc: Anticipate Extending Our Runway Into 2H 2027 and Past Alstars Topline Readout

THOMSON REUTERS

Coya Therapeutics Qtrly EPS $-0.13

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/COYA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COYA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COYA\",,,,,undefined,":{"symbol":"COYA","market":"US","secType":"STK","nameCN":"COYA THERAPEUTICS INC","latestPrice":4.28,"timestamp":1768597200000,"preClose":4.03,"halted":0,"volume":385311,"hourTrading":{"tag":"盘后","latestPrice":4.28,"preClose":4.28,"latestTime":"18:49 EST","volume":283,"amount":1210.2,"timestamp":1768607360969,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.06203473945409429,"floatShares":16831400,"shares":20924500,"eps":-1.108176,"marketStatus":"Closed Martin Luther King, Jr. Day","change":0.25,"latestTime":"01-16 16:00:00 EST","open":4.11,"high":4.37,"low":4.0612,"amount":1635794.888323,"amplitude":0.076625,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.108176,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1768899600000},"marketStatusCode":7,"adr":0,"listingDate":1672290000000,"exchange":"NASDAQ","adjPreClose":4.03,"preHourTrading":{"tag":"盘前","latestPrice":4.2,"preClose":4.03,"latestTime":"09:27 EST","volume":7882,"amount":33007.438789,"timestamp":1768573654767,"change":0.17,"changeRate":0.042184,"amplitude":0.024814},"postHourTrading":{"tag":"盘后","latestPrice":4.28,"preClose":4.28,"latestTime":"18:49 EST","volume":283,"amount":1210.2,"timestamp":1768607360969,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.748874097076683,"impliedVol":3.5764,"impliedVolPercentile":0.8952},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COYA\",,,,,undefined,":{"symbol":"COYA","floatShares":16831400,"roa":"-37.15%","roe":"-62.18%","lyrEps":-0.976498,"volumeRatio":0.748874097076683,"shares":20924500,"dividePrice":0,"high":4.37,"amplitude":0.076625,"preClose":4.03,"low":4.0612,"week52Low":3.9401,"pbRate":"3.28","psRate":"22.46","week52High":8.29,"institutionHeld":0,"latestPrice":4.28,"eps":-1.108176,"divideRate":0,"volume":385311,"delay":0,"ttmEps":-1.108176,"open":4.11,"prevYearClose":5.8,"prevWeekClose":4.28,"prevMonthClose":5.8,"prevQuarterClose":5.8,"fiveDayClose":4.85,"twentyDayClose":5.6,"sixtyDayClose":6.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COYA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"COYA","fiscalQuarterEnding":"2025/09","expectedEps":0.02,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.1},{"market":"US","date":"2025-08-12","symbol":"COYA","fiscalQuarterEnding":"2025/06","expectedEps":-0.22,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.36}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COYA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"COYA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.8571,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8571,"analysts":7,"updateTime":1752037200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/COYA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"COYA","date":"2026-01-16","current":-3.862202,"percent":0.692206,"low":-18.170827,"twenty":-10.039554,"median":-6.190468,"eighty":-3.858435,"high":-2.532969,"avg":-7.106687,"sd":3.476987,"marketCap":84325557},"quantilePoints":[{"date":"2022-12-30","current":-4.259584,"twenty":-5.088378,"median":-4.673981,"eighty":-4.199135,"marketCap":45862003},{"date":"2023-01-06","current":-4.198451,"twenty":-4.75686,"median":-4.211892,"eighty":-4.164199,"marketCap":45203803},{"date":"2023-01-13","current":-4.315322,"twenty":-4.421315,"median":-4.259584,"eighty":-4.180381,"marketCap":46462126},{"date":"2023-01-20","current":-4.288262,"twenty":-4.396143,"median":-4.253021,"eighty":-4.180381,"marketCap":46170776},{"date":"2023-01-27","current":-4.181765,"twenty":-4.394298,"median":-4.256303,"eighty":-4.180658,"marketCap":45024142},{"date":"2023-02-03","current":-3.675163,"twenty":-4.351211,"median":-4.234322,"eighty":-4.117451,"marketCap":39569675},{"date":"2023-02-10","current":-3.877804,"twenty":-4.30991,"median":-4.190108,"eighty":-3.84096,"marketCap":41751462},{"date":"2023-02-17","current":-3.850171,"twenty":-4.288262,"median":-4.180381,"eighty":-3.855698,"marketCap":41453946},{"date":"2023-02-24","current":-3.684374,"twenty":-4.288262,"median":-4.153411,"eighty":-3.785695,"marketCap":39668848},{"date":"2023-03-03","current":-4.089655,"twenty":-4.270282,"median":-4.071233,"eighty":-3.770128,"marketCap":44032421},{"date":"2023-03-10","current":-4.23703,"twenty":-4.288262,"median":-4.153411,"eighty":-3.785695,"marketCap":45619175},{"date":"2023-03-17","current":-3.905437,"twenty":-4.29377,"median":-4.180381,"eighty":-3.822538,"marketCap":42048978},{"date":"2023-03-24","current":-3.73964,"twenty":-4.288262,"median":-4.108461,"eighty":-3.73964,"marketCap":40263880},{"date":"2023-03-31","current":-3.218192,"twenty":-4.288262,"median":-4.048207,"eighty":-3.707402,"marketCap":39406041},{"date":"2023-04-06","current":-3.099387,"twenty":-4.273878,"median":-3.979124,"eighty":-3.684448,"marketCap":37951295},{"date":"2023-04-14","current":-3.233436,"twenty":-4.261724,"median":-3.905437,"eighty":-3.63832,"marketCap":39592701},{"date":"2023-04-21","current":-3.534032,"twenty":-4.256278,"median":-3.877804,"eighty":-3.512909,"marketCap":43273430},{"date":"2023-04-28","current":-3.753386,"twenty":-4.253993,"median":-3.850523,"eighty":-3.541339,"marketCap":45959367},{"date":"2023-05-05","current":-4.053981,"twenty":-4.248953,"median":-3.850876,"eighty":-3.590423,"marketCap":49640095},{"date":"2023-05-12","current":-3.858435,"twenty":-4.25448,"median":-3.877804,"eighty":-3.627267,"marketCap":51231762},{"date":"2023-05-19","current":-4.210564,"twenty":-4.257931,"median":-3.905437,"eighty":-3.63832,"marketCap":55907282},{"date":"2023-05-26","current":-3.109224,"twenty":-4.25448,"median":-3.877804,"eighty":-3.560217,"marketCap":41283847},{"date":"2023-06-02","current":-3.431385,"twenty":-4.251665,"median":-3.850876,"eighty":-3.429011,"marketCap":45561450},{"date":"2023-06-09","current":-3.611196,"twenty":-4.244399,"median":-3.84096,"eighty":-3.421013,"marketCap":47948950},{"date":"2023-06-16","current":-3.618688,"twenty":-4.23703,"median":-3.850171,"eighty":-3.424798,"marketCap":48048429},{"date":"2023-06-23","current":-3.566243,"twenty":-4.23703,"median":-3.830566,"eighty":-3.428417,"marketCap":47352075},{"date":"2023-06-30","current":-3.146685,"twenty":-4.23703,"median":-3.818461,"eighty":-3.418016,"marketCap":41781243},{"date":"2023-07-07","current":-3.071764,"twenty":-4.235405,"median":-3.785695,"eighty":-3.362458,"marketCap":40786451},{"date":"2023-07-14","current":-3.041795,"twenty":-4.228928,"median":-3.76675,"eighty":-3.288681,"marketCap":40388534},{"date":"2023-07-21","current":-2.981859,"twenty":-4.224887,"median":-3.746054,"eighty":-3.233436,"marketCap":39592701},{"date":"2023-07-28","current":-3.019319,"twenty":-4.216174,"median":-3.721218,"eighty":-3.218192,"marketCap":40090097},{"date":"2023-08-04","current":-2.876969,"twenty":-4.203296,"median":-3.712007,"eighty":-3.16841,"marketCap":38199993},{"date":"2023-08-11","current":-2.839996,"twenty":-4.188439,"median":-3.693585,"eighty":-3.145639,"marketCap":36807285},{"date":"2023-08-18","current":-2.54832,"twenty":-4.180935,"median":-3.684466,"eighty":-3.105289,"marketCap":33027077},{"date":"2023-08-25","current":-2.709509,"twenty":-4.180381,"median":-3.675163,"eighty":-3.078507,"marketCap":35116139},{"date":"2023-09-01","current":-2.709509,"twenty":-4.180381,"median":-3.63832,"eighty":-3.046291,"marketCap":35116139},{"date":"2023-09-08","current":-3.691995,"twenty":-4.169593,"median":-3.63832,"eighty":-3.044792,"marketCap":47849471},{"date":"2023-09-15","current":-3.546157,"twenty":-4.135431,"median":-3.63832,"eighty":-3.058278,"marketCap":45959367},{"date":"2023-09-21","current":-3.031887,"twenty":-4.1047,"median":-3.619293,"eighty":-3.053783,"marketCap":39294264},{"date":"2023-09-29","current":-3.162374,"twenty":-4.08252,"median":-3.599887,"eighty":-3.071764,"marketCap":40985409},{"date":"2023-10-06","current":-2.594374,"twenty":-4.053747,"median":-3.556227,"eighty":-3.033869,"marketCap":33623952},{"date":"2023-10-13","current":-3.745724,"twenty":-4.05097,"median":-3.54621,"eighty":-3.041795,"marketCap":48545825},{"date":"2023-10-20","current":-3.937616,"twenty":-4.036232,"median":-3.575206,"eighty":-3.043294,"marketCap":51032803},{"date":"2023-10-27","current":-3.645941,"twenty":-4.021495,"median":-3.590557,"eighty":-3.046291,"marketCap":47252596},{"date":"2023-11-03","current":-3.684319,"twenty":-3.985193,"median":-3.599887,"eighty":-3.062774,"marketCap":47749992},{"date":"2023-11-10","current":-3.870934,"twenty":-4.021495,"median":-3.619293,"eighty":-3.071764,"marketCap":47850465},{"date":"2023-11-17","current":-4.057134,"twenty":-4.055242,"median":-3.63832,"eighty":-3.071764,"marketCap":50152180},{"date":"2023-11-24","current":-4.259991,"twenty":-4.064747,"median":-3.645941,"eighty":-3.07577,"marketCap":52659789},{"date":"2023-12-01","current":-4.324905,"twenty":-4.105159,"median":-3.675163,"eighty":-3.082268,"marketCap":53462223},{"date":"2023-12-08","current":-5.631302,"twenty":-4.180381,"median":-3.684374,"eighty":-3.084048,"marketCap":69611225},{"date":"2023-12-15","current":-7.875233,"twenty":-4.205719,"median":-3.689056,"eighty":-3.088687,"marketCap":97349529},{"date":"2023-12-22","current":-7.933482,"twenty":-4.235947,"median":-3.693585,"eighty":-3.093672,"marketCap":98069570},{"date":"2023-12-29","current":-8.842163,"twenty":-4.23703,"median":-3.709704,"eighty":-3.09424,"marketCap":109302208},{"date":"2024-01-05","current":-7.793685,"twenty":-4.253993,"median":-3.715021,"eighty":-3.09424,"marketCap":96341472},{"date":"2024-01-12","current":-7.877698,"twenty":-4.259991,"median":-3.721218,"eighty":-3.097328,"marketCap":97379997},{"date":"2024-01-19","current":-6.724011,"twenty":-4.272114,"median":-3.742682,"eighty":-3.100019,"marketCap":83118725},{"date":"2024-01-26","current":-6.99204,"twenty":-4.300291,"median":-3.753386,"eighty":-3.10427,"marketCap":86431950},{"date":"2024-02-02","current":-7.213454,"twenty":-4.321125,"median":-3.76675,"eighty":-3.109224,"marketCap":89168961},{"date":"2024-02-09","current":-7.935965,"twenty":-4.359055,"median":-3.785695,"eighty":-3.121212,"marketCap":98100263},{"date":"2024-02-16","current":-8.91485,"twenty":-4.404211,"median":-3.812795,"eighty":-3.139255,"marketCap":110200736},{"date":"2024-02-23","current":-10.04523,"twenty":-4.438913,"median":-3.822509,"eighty":-3.140292,"marketCap":124173901},{"date":"2024-03-01","current":-10.476406,"twenty":-5.628056,"median":-3.830566,"eighty":-3.144593,"marketCap":129503871},{"date":"2024-03-08","current":-10.441446,"twenty":-5.900696,"median":-3.837832,"eighty":-3.146685,"marketCap":129071712},{"date":"2024-03-15","current":-11.653399,"twenty":-6.72168,"median":-3.850171,"eighty":-3.146685,"marketCap":144053250},{"date":"2024-03-22","current":-18.042053,"twenty":-6.870845,"median":-3.854655,"eighty":-3.146752,"marketCap":144116957},{"date":"2024-03-28","current":-17.568699,"twenty":-6.99204,"median":-3.858435,"eighty":-3.147022,"marketCap":140335887},{"date":"2024-04-05","current":-16.744948,"twenty":-7.213454,"median":-3.877804,"eighty":-3.154698,"marketCap":133755895},{"date":"2024-04-12","current":-16.708387,"twenty":-7.481482,"median":-3.895399,"eighty":-3.162374,"marketCap":133463852},{"date":"2024-04-19","current":-15.428751,"twenty":-7.933482,"median":-3.905437,"eighty":-3.168361,"marketCap":123242331},{"date":"2024-04-26","current":-15.41047,"twenty":-7.947618,"median":-3.91531,"eighty":-3.168442,"marketCap":123096309},{"date":"2024-05-03","current":-16.050288,"twenty":-8.108228,"median":-3.925864,"eighty":-3.184145,"marketCap":128207070},{"date":"2024-05-10","current":-15.465312,"twenty":-8.157379,"median":-3.945867,"eighty":-3.193076,"marketCap":123534375},{"date":"2024-05-17","current":-12.046492,"twenty":-8.434421,"median":-4.006757,"eighty":-3.19913,"marketCap":124118462},{"date":"2024-05-24","current":-12.027546,"twenty":-8.842163,"median":-4.037702,"eighty":-3.208428,"marketCap":123923260},{"date":"2024-05-31","current":-11.25722,"twenty":-9.523158,"median":-4.053396,"eighty":-3.216239,"marketCap":115986366},{"date":"2024-06-07","current":-10.62197,"twenty":-10.30363,"median":-4.063993,"eighty":-3.218192,"marketCap":109441204},{"date":"2024-06-14","current":-10.636743,"twenty":-10.491151,"median":-4.092919,"eighty":-3.222662,"marketCap":109593417},{"date":"2024-06-21","current":-8.937819,"twenty":-10.481448,"median":-4.104334,"eighty":-3.228445,"marketCap":92088913},{"date":"2024-06-28","current":-8.952592,"twenty":-10.45543,"median":-4.153411,"eighty":-3.232684,"marketCap":92241126},{"date":"2024-07-05","current":-9.602615,"twenty":-10.38956,"median":-4.180381,"eighty":-3.233436,"marketCap":98938502},{"date":"2024-07-12","current":-11.065167,"twenty":-10.462422,"median":-4.190108,"eighty":-3.233436,"marketCap":114007596},{"date":"2024-07-19","current":-10.341278,"twenty":-10.495432,"median":-4.22459,"eighty":-3.240692,"marketCap":106549156},{"date":"2024-07-26","current":-10.858342,"twenty":-10.601287,"median":-4.235676,"eighty":-3.260565,"marketCap":111876613},{"date":"2024-08-02","current":-9.30715,"twenty":-10.601287,"median":-4.23703,"eighty":-3.276491,"marketCap":95894240},{"date":"2024-08-09","current":-8.952592,"twenty":-10.592423,"median":-4.254237,"eighty":-3.285234,"marketCap":92241126},{"date":"2024-08-16","current":-7.71646,"twenty":-10.555339,"median":-4.259991,"eighty":-3.293463,"marketCap":77933096},{"date":"2024-08-23","current":-9.253723,"twenty":-10.495432,"median":-4.262601,"eighty":-3.309966,"marketCap":93458831},{"date":"2024-08-30","current":-9.08794,"twenty":-10.483969,"median":-4.273335,"eighty":-3.333614,"marketCap":91784487},{"date":"2024-09-06","current":-9.057798,"twenty":-10.475972,"median":-4.288262,"eighty":-3.336985,"marketCap":91480061},{"date":"2024-09-13","current":-9.645575,"twenty":-10.467679,"median":-4.305376,"eighty":-3.353467,"marketCap":97416371},{"date":"2024-09-20","current":-9.20851,"twenty":-10.421412,"median":-4.315454,"eighty":-3.374246,"marketCap":93002191},{"date":"2024-09-27","current":-10.188138,"twenty":-10.338323,"median":-4.344348,"eighty":-3.38688,"marketCap":102896042},{"date":"2024-10-04","current":-10.941699,"twenty":-10.338323,"median":-4.360183,"eighty":-3.395897,"marketCap":110506696},{"date":"2024-10-11","current":-10.625204,"twenty":-10.475972,"median":-4.389011,"eighty":-3.411186,"marketCap":107310221},{"date":"2024-10-18","current":-12.056969,"twenty":-10.583908,"median":-4.422276,"eighty":-3.421013,"marketCap":121770464},{"date":"2024-10-25","current":-13.503805,"twenty":-10.624557,"median":-4.764496,"eighty":-3.424798,"marketCap":136382919},{"date":"2024-11-01","current":-10.610132,"twenty":-10.639569,"median":-5.615074,"eighty":-3.429011,"marketCap":107158008},{"date":"2024-11-08","current":-11.259019,"twenty":-10.689241,"median":-5.753016,"eighty":-3.447868,"marketCap":120460649},{"date":"2024-11-15","current":-9.869209,"twenty":-10.838842,"median":-5.907187,"eighty":-3.515296,"marketCap":105591027},{"date":"2024-11-22","current":-10.150294,"twenty":-10.747842,"median":-6.613304,"eighty":-3.52129,"marketCap":108598366},{"date":"2024-11-29","current":-10.181526,"twenty":-10.695836,"median":-6.758971,"eighty":-3.52129,"marketCap":108932515},{"date":"2024-12-06","current":-9.556893,"twenty":-10.66286,"median":-6.852199,"eighty":-3.534032,"marketCap":102249538},{"date":"2024-12-13","current":-9.197728,"twenty":-10.640275,"median":-6.968732,"eighty":-3.546157,"marketCap":98406827},{"date":"2024-12-20","current":-8.182699,"twenty":-10.636743,"median":-6.99204,"eighty":-3.54621,"marketCap":87546990},{"date":"2024-12-27","current":-9.244576,"twenty":-10.634857,"median":-7.16684,"eighty":-3.558448,"marketCap":98908050},{"date":"2025-01-03","current":-9.541277,"twenty":-10.628876,"median":-7.256788,"eighty":-3.564349,"marketCap":102082464},{"date":"2025-01-10","current":-9.010338,"twenty":-10.62391,"median":-7.341641,"eighty":-3.567419,"marketCap":96401934},{"date":"2025-01-17","current":-8.401321,"twenty":-10.617235,"median":-7.51608,"eighty":-3.569184,"marketCap":89886032},{"date":"2025-01-24","current":-9.213344,"twenty":-10.609545,"median":-7.731531,"eighty":-3.571593,"marketCap":98573901},{"date":"2025-01-31","current":-9.494429,"twenty":-10.604242,"median":-7.875233,"eighty":-3.584959,"marketCap":101581241},{"date":"2025-02-07","current":-10.665617,"twenty":-10.609545,"median":-7.934724,"eighty":-3.602149,"marketCap":114111822},{"date":"2025-02-14","current":-10.61877,"twenty":-10.62133,"median":-7.947618,"eighty":-3.612694,"marketCap":113610598},{"date":"2025-02-21","current":-10.009752,"twenty":-10.61877,"median":-7.957599,"eighty":-3.618688,"marketCap":107094696},{"date":"2025-02-28","current":-11.056013,"twenty":-10.61877,"median":-8.042226,"eighty":-3.619898,"marketCap":118288682},{"date":"2025-03-07","current":-10.743696,"twenty":-10.62197,"median":-8.108228,"eighty":-3.622913,"marketCap":114947194},{"date":"2025-03-14","current":-10.134679,"twenty":-10.61877,"median":-8.140788,"eighty":-3.63832,"marketCap":108431292},{"date":"2025-03-21","current":-7.507868,"twenty":-10.61877,"median":-8.131528,"eighty":-3.63832,"marketCap":111722986},{"date":"2025-03-28","current":-7.372996,"twenty":-10.610132,"median":-8.0597,"eighty":-3.645941,"marketCap":109715986},{"date":"2025-04-04","current":-6.125431,"twenty":-10.607197,"median":-8.00338,"eighty":-3.648656,"marketCap":91151239},{"date":"2025-04-11","current":-5.81073,"twenty":-10.603154,"median":-7.947618,"eighty":-3.675163,"marketCap":86468239},{"date":"2025-04-17","current":-5.911884,"twenty":-10.594569,"median":-7.935965,"eighty":-3.675163,"marketCap":87973489},{"date":"2025-04-25","current":-6.945902,"twenty":-10.592423,"median":-7.877698,"eighty":-3.682488,"marketCap":103360487},{"date":"2025-05-02","current":-7.159449,"twenty":-10.558363,"median":-7.770143,"eighty":-3.684363,"marketCap":106538237},{"date":"2025-05-09","current":-6.799791,"twenty":-10.517537,"median":-7.71646,"eighty":-3.684448,"marketCap":101186237},{"date":"2025-05-16","current":-5.787895,"twenty":-10.501662,"median":-7.494675,"eighty":-3.685787,"marketCap":99179238},{"date":"2025-05-23","current":-5.573167,"twenty":-10.491151,"median":-7.462911,"eighty":-3.690819,"marketCap":95499738},{"date":"2025-05-30","current":-5.204226,"twenty":-10.481448,"median":-7.372996,"eighty":-3.692949,"marketCap":89177689},{"date":"2025-06-06","current":-5.631729,"twenty":-10.475105,"median":-7.356137,"eighty":-3.693585,"marketCap":96503238},{"date":"2025-06-13","current":-5.241315,"twenty":-10.467261,"median":-7.341641,"eighty":-3.701875,"marketCap":89813239},{"date":"2025-06-20","current":-5.37796,"twenty":-10.461335,"median":-7.3168,"eighty":-3.709244,"marketCap":92154738},{"date":"2025-06-27","current":-5.758614,"twenty":-10.45223,"median":-7.265955,"eighty":-3.713213,"marketCap":98677488},{"date":"2025-07-03","current":-5.817176,"twenty":-10.430063,"median":-7.253076,"eighty":-3.716195,"marketCap":99680988},{"date":"2025-07-11","current":-6.17343,"twenty":-10.378286,"median":-7.213454,"eighty":-3.720955,"marketCap":105785612},{"date":"2025-07-18","current":-5.817176,"twenty":-10.3533,"median":-7.163144,"eighty":-3.721218,"marketCap":99680988},{"date":"2025-07-25","current":-6.558964,"twenty":-10.350896,"median":-7.092013,"eighty":-3.724902,"marketCap":112391986},{"date":"2025-08-01","current":-5.807416,"twenty":-10.338323,"median":-6.99204,"eighty":-3.740857,"marketCap":99513738},{"date":"2025-08-08","current":-5.953821,"twenty":-10.32596,"median":-6.97962,"eighty":-3.74579,"marketCap":102022487},{"date":"2025-08-15","current":-4.674882,"twenty":-10.323437,"median":-6.940283,"eighty":-3.74752,"marketCap":95082085},{"date":"2025-08-22","current":-5.41908,"twenty":-10.320001,"median":-6.875506,"eighty":-3.754924,"marketCap":110218283},{"date":"2025-08-29","current":-5.517759,"twenty":-10.309706,"median":-6.854093,"eighty":-3.761854,"marketCap":112225293},{"date":"2025-09-05","current":-5.246393,"twenty":-10.301605,"median":-6.808515,"eighty":-3.76497,"marketCap":106706016},{"date":"2025-09-12","current":-5.106599,"twenty":-10.301173,"median":-6.724011,"eighty":-3.76853,"marketCap":103862753},{"date":"2025-09-19","current":-4.720109,"twenty":-10.296958,"median":-6.63442,"eighty":-3.770128,"marketCap":96001964},{"date":"2025-09-26","current":-4.366512,"twenty":-10.282185,"median":-6.51425,"eighty":-3.785695,"marketCap":88810180},{"date":"2025-10-03","current":-4.827011,"twenty":-10.275221,"median":-6.439507,"eighty":-3.802131,"marketCap":98176225},{"date":"2025-10-10","current":-5.155938,"twenty":-10.212758,"median":-6.246632,"eighty":-3.807129,"marketCap":104866257},{"date":"2025-10-17","current":-5.180608,"twenty":-10.197142,"median":-6.190468,"eighty":-3.818461,"marketCap":105368010},{"date":"2025-10-24","current":-5.739785,"twenty":-10.188138,"median":-6.125431,"eighty":-3.822481,"marketCap":116741065},{"date":"2025-10-31","current":-5.03259,"twenty":-10.181526,"median":-6.064471,"eighty":-3.822538,"marketCap":102357495},{"date":"2025-11-07","current":-4.736556,"twenty":-10.181526,"median":-6.012384,"eighty":-3.830156,"marketCap":96336466},{"date":"2025-11-14","current":-4.901019,"twenty":-10.157996,"median":-5.968462,"eighty":-3.830566,"marketCap":99681482},{"date":"2025-11-21","current":-6.788148,"twenty":-10.150294,"median":-6.012384,"eighty":-3.831749,"marketCap":125128246},{"date":"2025-11-28","current":-7.389773,"twenty":-10.150294,"median":-6.057995,"eighty":-3.836615,"marketCap":136218208},{"date":"2025-12-05","current":-6.810851,"twenty":-10.140824,"median":-6.125431,"eighty":-3.837832,"marketCap":125546736},{"date":"2025-12-12","current":-7.094636,"twenty":-10.135435,"median":-6.18807,"eighty":-3.843973,"marketCap":130777850},{"date":"2025-12-19","current":-6.016252,"twenty":-10.134497,"median":-6.219749,"eighty":-3.849238,"marketCap":110899616},{"date":"2025-12-26","current":-6.300037,"twenty":-10.125219,"median":-6.23928,"eighty":-3.850171,"marketCap":116130730},{"date":"2026-01-02","current":-6.583822,"twenty":-10.098465,"median":-6.246632,"eighty":-3.850453,"marketCap":121361844},{"date":"2026-01-09","current":-5.811926,"twenty":-10.058633,"median":-6.231928,"eighty":-3.8539,"marketCap":107133214},{"date":"2026-01-16","current":-4.574621,"twenty":-10.039554,"median":-6.190468,"eighty":-3.858435,"marketCap":84325557}],"updateTime":1768837698808},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COYA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2602371826","title":"Coya Therapeutics, Inc. (COYA) Receives a Buy from Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2602371826","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602371826?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:56","pubTimestamp":1767966975,"startTime":"0","endTime":"0","summary":"In a report released today, Chad Messer from Lake Street maintained a Buy rating on Coya Therapeutics, Inc., with a price target of $17.00. Accordi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/coya-therapeutics-inc-coya-receives-a-buy-from-lake-street-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/coya-therapeutics-inc-coya-receives-a-buy-from-lake-street-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2602732732","title":"COYA-302: De-Risked Treg Platform With Compelling FTD Data and ALS Phase 2 Catalyst Supporting Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2602732732","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602732732?lang=en_us&edition=fundamental","pubTime":"2026-01-09 18:56","pubTimestamp":1767956160,"startTime":"0","endTime":"0","summary":"Analyst Thomas Shrader of BTIG maintained a Buy rating on Coya Therapeutics, Inc., retaining the price target of $16.00. Thomas Shrader has given h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/coya-302-de-risked-treg-platform-with-compelling-ftd-data-and-als-phase-2-catalyst-supporting-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/coya-302-de-risked-treg-platform-with-compelling-ftd-data-and-als-phase-2-catalyst-supporting-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COYA"],"gpt_icon":0},{"id":"2601839332","title":"Coya Therapeutics: Early COYA 302 Validation, Regulatory De-Risking, and Upcoming Catalysts Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2601839332","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601839332?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:45","pubTimestamp":1767883549,"startTime":"0","endTime":"0","summary":"Ram Selvaraju, an analyst from H.C. Wainwright, reiterated the Buy rating on Coya Therapeutics, Inc.. The associated price target remains the same ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/coya-therapeutics-early-coya-302-validation-regulatory-de-risking-and-upcoming-catalysts-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/coya-therapeutics-early-coya-302-validation-regulatory-de-risking-and-upcoming-catalysts-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COYA"],"gpt_icon":0},{"id":"2601627023","title":"BRIEF-Coya Therapeutics Announces Results Of Investigator-Initiated Study Of Ld Il-2 And Ctla4-Ig","url":"https://stock-news.laohu8.com/highlight/detail?id=2601627023","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601627023?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:39","pubTimestamp":1767879578,"startTime":"0","endTime":"0","summary":"BRIEF-Coya Therapeutics Announces Results Of Investigator-Initiated Study Of Ld Il-2 And Ctla4-Ig Jan 8 (Reuters) - Coya Therapeutics Inc COYA.O:COYA THERAPEUTICS ANNOUNCES RESULTS OF INVESTIGATOR-INI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA4YVHHK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2601316364","title":"Coya Therapeutics Reports Positive Results from FTD Study of Low-Dose IL-2 and CTLA4-Ig Combination Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2601316364","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601316364?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:01","pubTimestamp":1767877292,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc. announced positive results from an investigator-initiated proof-of-concept open-label study evaluating a combination of low-dose IL-2 and CTLA4-Ig in nine patients with Frontotemporal Dementia . Over a 22-week treatment period, the study demonstrated enhanced regulatory T cell  numbers and function, as well as cognitive stability as measured by CDR-FTLD and Montreal Cognitive Assessment  scores. The most common adverse event was mild erythema at the injection site, with no serious adverse events reported. The results have already been presented. Coya Therapeutics plans to advance the combination, COYA 302, into a phase 2 clinical trial for FTD.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL71ZfjW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2601364897","title":"Coya Therapeutics Announces Results of Investigator-Initiated Study of Ld Il-2 and Ctla4-Ig Demonstrating Treg Enhancement and Cognitive Stability in Frontotemporal Dementia Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2601364897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601364897?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:00","pubTimestamp":1767877203,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA4YVHHK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2601488283","title":"BRIEF-Coya Therapeutics Announces U.S. FDA Acceptance Of Investigational New Drug Application For COYA 302","url":"https://stock-news.laohu8.com/highlight/detail?id=2601488283","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601488283?lang=en_us&edition=fundamental","pubTime":"2026-01-05 22:00","pubTimestamp":1767621646,"startTime":"0","endTime":"0","summary":"BRIEF-Coya Therapeutics Announces U.S. FDA Acceptance Of Investigational New Drug Application For COYA 302 Jan 5 (Reuters) - Coya Therapeutics Inc COYA.O:COYA THERAPEUTICS ANNOUNCES U.S. FDA ACCEPTANC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nTUA4XBKLB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2601810881","title":"FDA Accepts IND Application for Coya Therapeutics’ COYA 302 for Frontotemporal Dementia","url":"https://stock-news.laohu8.com/highlight/detail?id=2601810881","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601810881?lang=en_us&edition=fundamental","pubTime":"2026-01-05 21:01","pubTimestamp":1767618105,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc., a clinical-stage biotechnology company focused on developing biologics to enhance regulatory T cell  function in neurodegenerative disorders, announced that the U.S. Food and Drug Administration  has accepted its Investigational New Drug  application for COYA 302 for the treatment of frontotemporal dementia . This acceptance enables Coya to advance COYA 302 into clinical trials for FTD, a disease with significant unmet medical needs and no approved disease-modifying treatments.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on January 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDLbyzb28:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2601088909","title":"Coya Therapeutics Announces U.S. FDA Acceptance of Investigational New Drug (Ind) Application for Coya 302 for the Treatment of Frontotemporal Dementia (Ftd)","url":"https://stock-news.laohu8.com/highlight/detail?id=2601088909","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601088909?lang=en_us&edition=fundamental","pubTime":"2026-01-05 21:00","pubTimestamp":1767618006,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nTUA4XBKLB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2593418647","title":"BRIEF-Coya Therapeutics Receives Clinical Trial Application Acceptance From Health Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2593418647","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593418647?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:20","pubTimestamp":1766496039,"startTime":"0","endTime":"0","summary":"BRIEF-Coya Therapeutics Receives Clinical Trial Application Acceptance From Health CanadaDec 23 (Reuters) - Coya Therapeutics Inc COYA.O:COYA THERAPEUTICS RECEIVES CLINICAL TRIAL APPLICATION (CTA) ACC","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nTUA8XNHFZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2593490407","title":"Coya Therapeutics Secures Health Canada Approval to Begin ALS Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2593490407","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593490407?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:00","pubTimestamp":1766494857,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc., a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell function in patients with neurodegenerative disorders, has received acceptance from Health Canada for its Clinical Trial Application  for COYA 302, a treatment for amyotrophic lateral sclerosis . This regulatory approval allows Coya to activate clinical trial sites in Canada, supporting and expanding patient recruitment efforts alongside ongoing U.S. sites for the ALSTARS Trial.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on December 23, 2025, and is solely responsible for the information contained therei","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL2HcgVr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2593490104","title":"Coya Therapeutics Inc - Alstars Trial Underway in US and Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2593490104","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593490104?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:00","pubTimestamp":1766494801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nTUA8XNHFZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2593349048","title":"Coya Therapeutics Receives Clinical Trial Application (Cta) Acceptance From Health Canada to Proceed With the Coya 302 Alstars Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2593349048","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593349048?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:00","pubTimestamp":1766494801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nTUA8XNHFZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2592901829","title":"Coya Therapeutics Receives $4.2 Million Milestone Payment for ALS Trial Initiation","url":"https://stock-news.laohu8.com/highlight/detail?id=2592901829","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592901829?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:01","pubTimestamp":1765976517,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc. announced that it has received a $4.2 million milestone payment under its Development and License Agreement with Dr. Reddy's Laboratories Ltd. and its affiliate, Dr. Reddy's Laboratories SA. The payment was triggered by the dosing of the first patient in the company's ALSTARS trial evaluating COYA 302 for the treatment of amyotrophic lateral sclerosis .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL77zSl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2590349830","title":"Coya Therapeutics Begins Dosing ALS Patients in ALSTARS Trial of COYA 302","url":"https://stock-news.laohu8.com/highlight/detail?id=2590349830","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590349830?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:00","pubTimestamp":1765285249,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc. has announced the commencement of patient dosing in the ALSTARS Trial, a Phase 2, randomized, multi-center, double-blind, placebo-controlled study evaluating the efficacy and safety of COYA 302 for the treatment of amyotrophic lateral sclerosis . COYA 302 is an investigational biologic combination therapy designed to enhance regulatory T cell function and suppress inflammatory myeloid activity. The trial is currently underway, and results have not yet been presented. COYA 302 is not approved by the FDA or any other regulatory agency.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on December 09, 2025, and is ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL9M4thh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2590460203","title":"Coya Therapeutics Announces Patients Have Been Dosed in the Alstars Trial of Coya 302 for the Treatment of ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2590460203","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590460203?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:00","pubTimestamp":1765285203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nTUA8G480R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2586462473","title":"Coya Therapeutics to Join Evercore Healthcare and CTAD Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2586462473","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586462473?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:00","pubTimestamp":1764075634,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc. will participate in the 8th Annual Evercore Healthcare Conference on December 2, 2025, in Miami, FL, with CEO Dr. Arun Swaminathan joining a fireside chat. On the same day, Dr. Fred Grossman, President and Chief Medical Officer, will take part in a roundtable discussion at the 18th Clinical Trials on Alzheimer's Disease  Conference in San Diego, CA.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on November 25, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL4lWyZy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","EVR","COYA","BK4139"],"gpt_icon":0},{"id":"2582379797","title":"Coya Therapeutics reports $3.6 million collaboration revenue for Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2582379797","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582379797?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:02","pubTimestamp":1762952578,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc. reported collaboration revenues of $3.6 million for the three months ended September 30, 2025, primarily due to the recognition of $3.3 million in license revenue following FDA acceptance of its IND for a Phase 2 study. Research and development expenses were $2.9 million, up from $2.2 million in the same period last year, mainly due to increased clinical and internal research costs. General and administrative expenses rose to $2.6 million from $2.2 million. Net loss was $2.1 million, compared to a net loss of $4.0 million for the same period in 2024. As of September 30, 2025, cash and cash equivalents totaled $28.1 million. During the quarter, Coya announced FDA acceptance of its IND application for COYA 302 for ALS, received a $4.2 million milestone payment from Dr. Reddy's Laboratories, and closed a $23.0 million public offering, extending its cash runway into the second half of 2027.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL2Fp6k3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2582814371","title":"Coya Therapeutics Inc: Anticipate Extending Our Runway Into 2H 2027 and Past Alstars Topline Readout","url":"https://stock-news.laohu8.com/highlight/detail?id=2582814371","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582814371?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:00","pubTimestamp":1762952407,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nTUA6SLJ7P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2582371898","title":"Coya Therapeutics Qtrly EPS $-0.13","url":"https://stock-news.laohu8.com/highlight/detail?id=2582371898","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582371898?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:00","pubTimestamp":1762952407,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nTUA6SLJ7P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","COYA"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":65,"code":"91000000","status":"200"}]}}